Gemba; Takefumi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gemba; Takefumi.The latest application filed is for "chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator".

Company Profile

1.13.11

Gemba; Takefumi - Kagoshima JP
Gemba; Takefumi - Kawanishi-Hyogo JP
Gemba; Takefumi - Kagoshima-Shi JP
Gemba; Takefumi - Kawanishi N/A JP
Gemba; Takefumi - Kawanishi-shi JP
Gemba; Takefumi - Hyogo JP
Gemba; Takefumi - Amagasaki JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent Grant 10,322,173 - Gemba , et al.	2019-06-18
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent Grant 10,149,905 - Gemba , et al. Dec	2018-12-11
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator Grant 10,144,933 - Gemba , et al. De	2018-12-04
Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide Grant 9,695,219 - Gemba , et al. July 4, 2	2017-07-04
Chiral nucleic acid adjuvant Grant 9,617,547 - Gemba April 11, 2	2017-04-11
Chiral Nucleic Acid Adjuvant Having Antitumor Effect And Antitumor Agent App 20160331836 - Gemba; Takefumi ; et al.	2016-11-17
Chiral Nucleic Acid Adjuvant Having Anti-allergic Activity, And Anti-allergic Agent App 20160331835 - Gemba; Takefumi ; et al.	2016-11-17
Chiral Nucleic Acid Adjuvant Having Immunity Induction Activity, And Immunity Induction Activator App 20160333349 - GEMBA; Takefumi ; et al.	2016-11-17
Polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes Grant 9,376,470 - Gemba , et al. June 28, 2	2016-06-28
Chiral Nucleic Acid Adjuvant App 20150166999 - Gemba; Takefumi	2015-06-18
Polypeptide Having Antibacterial Activity and Angiogenesis-Inducing Activity and Wound-Healing Drug Containing Said Polypeptide App 20150133365 - Gemba; Takefumi ; et al.	2015-05-14
Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide Grant 8,969,311 - Gemba , et al. March 3, 2	2015-03-03
Polypeptides and antibacterial or antiseptic use of same Grant 8,470,765 - Gemba , et al. June 25, 2	2013-06-25
Polypeptide Having Antibacterial Activity and Angiogenesis-Inducing Activity and Wound-Healing Drug Containing Said Polypeptide App 20120172287 - Gemba; Takefumi ; et al.	2012-07-05
Novel Polypeptide Having Angiogenesis-Inducing Activity And Antibacterial Activity, And Use Thereof For Medical Purposes App 20120122766 - Gemba; Takefumi ; et al.	2012-05-17
Polypeptides and Antibacterial or Antiseptic Use of Same App 20120052104 - Gemba; Takefumi ; et al.	2012-03-01
Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc Grant 7,585,848 - Masuda , et al. September 8, 2	2009-09-08
Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension App 20090215868 - Otsu; Kunimiki ; et al.	2009-08-27
Transcription factor decoy App 20090143319 - Gemba; Takefumi ; et al.	2009-06-04
Decomposition inhibitor for extracellular matrix of cartilage App 20050227994 - Gemba, Takefumi ; et al.	2005-10-13
Formulation useful for the inhibition of massive release of cerebral glutamate Grant 5,242,915 - Ueda , et al. September 7, 1	1993-09-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.